Skip to content

Apotheek Bailli-Louise: what changed

BE 0885.672.653NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€24,331
2024 · €10,151+€14,180
Equity
€291,225
2024 · €266,894+€24,331
Cash
€157,555
2024 · €91,562+€65,993
Balance sheet total
€674,336
2024 · €425,551+€248,785

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€160,404

    up €160,404 (+216%), from €74,208 to €234,612

    of which Trade receivables: +€116,784

  • Cash +€65,993

    up €65,993 (+72.1%), from €91,562 to €157,555

    mainly Trade debts (+€239,103) and Net result for the year (+€24,331)

  • Tangible fixed assets +€57,937

    up €57,937 (+2,174%), from €2,665 to €60,602

    of which Other tangible fixed assets: +€55,729

  • Stocks and contracts -€20,783

    down €20,783 (-11.1%), from €187,088 to €166,305

  • Intangible fixed assets -€14,000

    down €14,000 (-30.8%), from €45,500 to €31,500

Equity and liabilities
  • Trade debts +€239,103

    up €239,103 (+215%), from €111,089 to €350,192

  • Profit (loss) carried forward +€24,331

    first reported in 2025, at €24,331

  • Tax, wage and social debts -€10,699

    down €10,699 (-32.6%), from €32,813 to €22,114

    of which Remuneration and social security: -€14,496

Income statement
  • Gross operating margin +€25,702

    up €25,702 (+13.8%), from €186,515 to €212,217

  • Financial charges +€10,481

    up €10,481 (+2,036%), from €515 to €10,996

    of which Financial charges: +€10,581

  • Staff costs -€7,157

    down €7,157 (-4.5%), from €158,152 to €150,995

  • Taxes +€5,194

    up €5,194 (+148%), from €3,516 to €8,709

  • Depreciation +€3,475

    up €3,475 (+24.5%), from €14,200 to €17,676

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €10,151
Gross operating margin +€25,702
Staff costs +€7,157
Depreciation -€3,475
Financial income +€471
Financial charges -€10,481
Taxes -€5,194
Result 2025 €24,331
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€127,605
Investment -€61,612
Financing €0
Cash 2024 €91,562
Net result for the year +€24,331
Depreciation +€17,676
Stocks and contracts +€20,783
Receivables within one year -€160,404
Deferred charges and accrued income +€765
Trade debts +€239,103
Tax, wage and social debts -€10,699
Other debts +€1,013
Accrued charges and deferred income -€4,963
Investment in fixed assets (net) -€61,612
Cash 2025 €157,555
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €425,551 €674,336 +€248,785 +58.5%
Fixed assets 21/28 €66,165 €110,102 +€43,937 +66.4%
Intangible fixed assets 21 €45,500 €31,500 -€14,000 -30.8%
Tangible fixed assets 22/27 €2,665 €60,602 +€57,937 +2,174%
Furniture and vehicles 24 €2,665 €4,873 +€2,208 +82.8%
Other tangible fixed assets 26 - €55,729 +€55,729
Financial fixed assets 28 €18,000 €18,000 = 0.0%
Current assets 29/58 €359,385 €564,233 +€204,848 +57.0%
Stocks and contracts in progress 3 €187,088 €166,305 -€20,783 -11.1%
Stocks 30/36 €187,088 €166,305 -€20,783 -11.1%
Amounts receivable within one year 40/41 €74,208 €234,612 +€160,404 +216%
Trade receivables 40 €54,485 €171,269 +€116,784 +214%
Other amounts receivable 41 €19,723 €63,343 +€43,619 +221%
Cash at bank and in hand 54/58 €91,562 €157,555 +€65,993 +72.1%
Deferred charges and accrued income 490/1 €6,527 €5,762 -€765 -11.7%
Total equity and liabilities 10/49 €425,551 €674,336 +€248,785 +58.5%
Equity 10/15 €266,894 €291,225 +€24,331 +9.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €248,294 €248,294 = 0.0%
Distributable reserves 133 €248,294 €248,294 = 0.0%
Profit (loss) carried forward 14 - €24,331 +€24,331
Amounts payable 17/49 €158,657 €383,111 +€224,455 +141%
Amounts payable within one year 42/48 €152,036 €381,454 +€229,417 +151%
Trade debts 44 €111,089 €350,192 +€239,103 +215%
Suppliers 440/4 €111,089 €350,192 +€239,103 +215%
Taxes, remuneration and social security 45 €32,813 €22,114 -€10,699 -32.6%
Taxes 450/3 €1,419 €5,216 +€3,797 +268%
Remuneration and social security 454/9 €31,394 €16,898 -€14,496 -46.2%
Other amounts payable 47/48 €8,134 €9,148 +€1,013 +12.5%
Accrued charges and deferred income 492/3 €6,621 €1,658 -€4,963 -75.0%
Remuneration, social security and pensions 62 €158,152 €150,995 -€7,157 -4.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,200 €17,676 +€3,475 +24.5%
Gross operating margin 9900 €186,515 €212,217 +€25,702 +13.8%
Operating profit (loss) 9901 €14,163 €43,547 +€29,383 +207%
Financial income 75/76B €18 €489 +€471 +2,641%
Recurring financial income 75 €18 €489 +€471 +2,641%
Financial charges 65/66B €515 €10,996 +€10,481 +2,036%
Recurring financial charges 65 €415 €10,996 +€10,581 +2,552%
Non-recurring financial charges 66B €100 - -€100
Profit (loss) for the period before taxes 9903 €13,666 €33,040 +€19,374 +142%
Income taxes 67/77 €3,516 €8,709 +€5,194 +148%
Profit (loss) for the period 9904 €10,151 €24,331 +€14,180 +140%
Profit (loss) for the period to be appropriated 9905 €10,151 €24,331 +€14,180 +140%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€211,205 to €243,742

Midpoint €224,762 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €259,725
Capitalised earnings €162,686 to €227,760
Indication €211,205 to €243,742

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€291,225
Intangible fixed assets (21)
-€31,500
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€259,725

Capitalised earnings

net result for the year (9904)
2025
€24,331
2024
€10,151
excluding non-recurring income and charges
€10,251
2023
€33,747
2022
€32,351
2021
€3,988
Average result, excluding non-recurring income and charges
€22,776
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€162,686 / €189,800 / €227,760

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.